UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
69.50 x 2 70.57 x 3
Pre-market by (Cboe BZX)
69.47 -2.66 (-3.69%) 03/27/25 [NASDAQ]
69.50 x 2 70.57 x 3
Pre-market 70.57 +1.10 (+1.58%) 07:33 ET
Quote Overview for Thu, Mar 27th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
71.47
Day High
73.40
Open 73.25
Previous Close 72.13 72.13
Volume 5,524,000 5,524,000
Avg Vol 4,464,545 4,464,545
Stochastic %K 28.53% 28.53%
Weighted Alpha -28.85 -28.85
5-Day Change -5.64 (-7.51%) -5.64 (-7.51%)
52-Week Range 62.34 - 141.99 62.34 - 141.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,146,932
  • Shares Outstanding, K 390,772
  • Annual Sales, $ 4,033 M
  • Annual Income, $ 576,200 K
  • EBIT $ 600 M
  • EBITDA $ 818 M
  • 60-Month Beta 1.28
  • Price/Sales 6.99
  • Price/Cash Flow 32.72
  • Price/Book 13.66

Options Overview Details

View History
  • Implied Volatility 42.94% ( -0.20%)
  • Historical Volatility 45.91%
  • IV Percentile 48%
  • IV Rank 30.87%
  • IV High 78.36% on 10/09/24
  • IV Low 27.12% on 05/16/24
  • Put/Call Vol Ratio 1.74
  • Today's Volume 8,583
  • Volume Avg (30-Day) 4,955
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 115,711
  • Open Int (30-Day) 126,687

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.33
  • Number of Estimates 11
  • High Estimate 0.43
  • Low Estimate 0.28
  • Prior Year 0.32
  • Growth Rate Est. (year over year) +3.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.30 +1.71%
on 03/13/25
Period Open: 87.81
88.74 -21.72%
on 03/03/25
-18.34 (-20.89%)
since 02/27/25
3-Month
68.30 +1.71%
on 03/13/25
Period Open: 80.24
93.25 -25.50%
on 02/18/25
-10.77 (-13.42%)
since 12/27/24
52-Week
62.34 +11.44%
on 07/26/24
Period Open: 139.48
141.99 -51.07%
on 04/09/24
-70.01 (-50.19%)
since 03/27/24

Most Recent Stories

More News
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the approval of the company’s upcoming 15-day G7 continuous glucose monitor (CGM). The...

BSX : 100.80 (-1.50%)
COR : 273.97 (+0.95%)
CAH : 136.65 (+1.99%)
DXCM : 69.47 (-3.69%)
DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With an...

BSX : 100.80 (-1.50%)
COR : 273.97 (+0.95%)
CAH : 136.65 (+1.99%)
DXCM : 69.47 (-3.69%)
DexCom (DXCM): 3 Reasons We Love This Stock

DexCom (DXCM): 3 Reasons We Love This Stock

DXCM : 69.47 (-3.69%)
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

RMD : 222.62 (+0.33%)
MASI : 168.47 (+1.23%)
PODD : 260.27 (-1.74%)
IRTC : 106.11 (+1.10%)
DXCM : 69.47 (-3.69%)
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this....

COMP : 9.34 (-0.53%)
VRTX : 502.55 (+0.45%)
DXCM : 69.47 (-3.69%)
Is DexCom Stock Underperforming the Dow?

DexCom significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s long term prospects.

DXCM : 69.47 (-3.69%)
STE : 224.23 (+0.52%)
$DOWI : 42,299.70 (-0.37%)
DXCM : 69.47 (-3.69%)
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

RMD : 222.62 (+0.33%)
MASI : 168.47 (+1.23%)
IRTC : 106.11 (+1.10%)
PODD : 260.27 (-1.74%)
DXCM : 69.47 (-3.69%)
Stocks Fall on Growth Fears and Tech Stock Plunge

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini...

MSTR : 324.59 (-1.43%)
GOOGL : 162.24 (-1.71%)
AAPL : 223.85 (+1.05%)
TAP : 60.96 (+0.66%)
HRL : 30.32 (+2.50%)
ADI : 208.94 (-0.76%)
ADM : 48.28 (+2.57%)
COIN : 188.58 (-2.77%)
TSLA : 273.13 (+0.39%)
CTSH : 77.58 (-0.35%)
^BTCUSD : 85,030.75 (-2.60%)
CME : 261.85 (-0.33%)
Stocks Drop on Tariff Anxiety and Economic Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -1.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -3.18%. March E-mini S&P futures...

MSTR : 324.59 (-1.43%)
GOOGL : 162.24 (-1.71%)
AAPL : 223.85 (+1.05%)
TAP : 60.96 (+0.66%)
HRL : 30.32 (+2.50%)
KHC : 30.07 (+1.28%)
ADM : 48.28 (+2.57%)
COIN : 188.58 (-2.77%)
TSLA : 273.13 (+0.39%)
CTSH : 77.58 (-0.35%)
^BTCUSD : 85,030.75 (-2.60%)
CME : 261.85 (-0.33%)
Stocks Set to Open Sharply Lower as U.S. Recession Talk Lingers, Inflation Data Awaited

March S&P 500 E-Mini futures (ESH25) are down -0.90%, and March Nasdaq 100 E-Mini futures (NQH25) are down -1.04% this morning, while Treasury yields also fell, as concerns about the health of the U.S....

MSTR : 324.59 (-1.43%)
MARA : 13.64 (-1.09%)
AVGO : 171.99 (-4.06%)
DG : 87.54 (+3.35%)
ULTA : 370.34 (-0.42%)
ORCL : 145.78 (-1.37%)
DKS : 210.09 (+1.55%)
DASH : 194.02 (+0.60%)
ESH25 : 5,617.80s (-0.79%)
WBA : 11.16 (+0.54%)
GAP : 21.23 (-0.70%)
ADBE : 396.15 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 74.55
2nd Resistance Point 73.51
1st Resistance Point 71.49
Last Price 69.47
1st Support Level 68.43
2nd Support Level 67.39
3rd Support Level 65.37

See More

52-Week High 141.99
Fibonacci 61.8% 111.56
Fibonacci 50% 102.17
Fibonacci 38.2% 92.77
Last Price 69.47
52-Week Low 62.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies